Govt To Get 3.5 Crore Covaxin Doses In August, Receiving 11-12 Crore Covishield Doses Per Month: Union Health MinisterUnion Minister of Health and Family Welfare Mansukh Mandaviya. (image via Mansukh Mandaviya/Facebook)

Union Minister for Health and Family Welfare Mansukh Mandaviya on Tuesday (20 July) said that the Hyderabad-based vaccine maker Bharat Biotech will be supplying 3.5 crore doses of Covaxin in August, reports Livemint.

Mandaviya also apprised the Rajya Sabha that the government was receiving 11-12 crore doses of Covishield from Pune-based Serum Institute of India (SII) per month.

He also informed the members of the Upper House that the Defence Research and Development Organisation (DRDO) has transferred the technology to produce 2DG drug to four pharma companies other than Hyderabad-based Dr Reddy's Laboratories.

The drug has been given emergency use authorization (EUA) as an adjunct therapy in moderate to severe COVID-19 patients. Mandaviya also informed the members that the complete clinical study report of Phase-III trials of DRDO's 2DG oral drug in moderate to severe patients is expected to be available by the end of August 2021.

Mandaviya made the statements while submitting the government's official reply on managing the pandemic.

An Appeal...

Dear Reader,

As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.

Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.

We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.

Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.

Become A Patron
Become A Subscriber
Advertisement